Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$185.15M-43.6% | -$162.45M-25.5% | -$149.96M-22.2% | -$142.3M-29.8% | -$128.89M-29.8% | ||
| $481K+11.1% | $490K+24.7% | $419K+14.8% | $471K+30.8% | $433K+18.6% | ||
| $23.36M+5.9% | $17.59M-22.1% | $19.64M-4.7% | $21.02M+10.1% | $22.05M+25.8% | ||
| -$148.72M-19.1% | -$146.72M-40.6% | -$134.67M-39.5% | -$127.16M-37.8% | -$124.83M-43.8% | ||
| —— | —— | —— | —— | -$118.47M-89.9% | ||
| $256.78M-1.3% | $211.3M-21.4% | $242.05M+867% | $242.1M+55.6% | $260.22M+83.2% | ||
| —— | —— | —— | —— | $16.92M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Olema Pharmaceuticals, Inc. generate?
- Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
- Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.